Premium
This is an archive article published on July 26, 2011

Strides Arcolab stock up on US FDA nod

Shares in Strides Arcolab Ltd rose by 5% after company received US FDA approval for Gemcitabine injection.

Shares in Strides Arcolab Ltd rose more than 5 per cent after the company said it has received US FDA approval for generic version of Gemcitabine injection used in the treatment of cancer,dealers said. At about 10 am shares were up 3.81 per cent to 381.55 rupees in a flat Mumbai market.

Company INFO

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement